- Review
Recent Advances in miRNA-Based Therapy for MASLD/MASH and MASH-Associated HCC
- Sara Carpi,
- Simona Daniele,
- Jacqueline Fátima Martins de Almeida and
- Daniela Gabbia
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is a growing health concern worldwide, affecting more than 1 billion adults. It may progress to metabolic dysfunction-assoc...